Cargando…
An exploratory study of circulating cytokines and chemokines in patients with muscle disorders proposes CD40L and CCL5 represent general disease markers while CXCL10 differentiates between patients with an autoimmune myositis
Discriminating an autoimmune myositis from other disorders and subtyping of patient groups within this heterogeneous group of conditions remain diagnostic challenges. In our study we explored the potential of cytokine and chemokine typing in patient sera as an addition to the expanding set of blood-...
Autores principales: | De Paepe, Boel, Bracke, Ken R., De Bleecker, Jan L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803590/ https://www.ncbi.nlm.nih.gov/pubmed/35128380 http://dx.doi.org/10.1016/j.cytox.2022.100063 |
Ejemplares similares
-
Retrospective Study Shows That Serum Levels of Chemokine CXCL10 and Cytokine GDF15 Support a Diagnosis of Sporadic Inclusion Body Myositis and Immune-Mediated Necrotizing Myopathy
por: De Paepe, Boel, et al.
Publicado: (2023) -
Cytokines and Chemokines as Regulators of Skeletal Muscle Inflammation: Presenting the Case of Duchenne Muscular Dystrophy
por: De Paepe, Boel, et al.
Publicado: (2013) -
Induction of Osmolyte Pathways in Skeletal Muscle Inflammation: Novel Biomarkers for Myositis
por: De Paepe, Boel, et al.
Publicado: (2018) -
Sporadic Inclusion Body Myositis: An Acquired Mitochondrial Disease with Extras
por: De Paepe, Boel
Publicado: (2019) -
Myo-Inositol Transporter SLC5A3 Associates with Degenerative Changes and Inflammation in Sporadic Inclusion Body Myositis
por: De Paepe, Boel, et al.
Publicado: (2020)